Lichen International Limited
LICN
$4.41
$0.11912.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.32% | 13.73% | 24.86% | 21.22% | 17.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.32% | 13.73% | 24.86% | 21.22% | 17.61% |
| Cost of Revenue | 2.36% | 9.76% | 17.95% | 15.71% | 13.41% |
| Gross Profit | 5.57% | 16.38% | 29.78% | 25.04% | 20.44% |
| SG&A Expenses | 150.60% | 86.14% | 20.72% | 23.24% | 26.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.37% | 44.04% | 19.23% | 19.00% | 18.75% |
| Operating Income | -137.12% | -67.19% | 43.69% | 27.15% | 15.13% |
| Income Before Tax | -136.00% | -62.08% | 61.18% | 28.82% | 7.88% |
| Income Tax Expenses | -40.06% | 0.86% | 64.01% | 33.28% | 11.15% |
| Earnings from Continuing Operations | -173.40% | -87.65% | 59.95% | 27.04% | 6.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -173.63% | -87.79% | 59.95% | 27.04% | 6.65% |
| EBIT | -137.12% | -67.19% | 43.69% | 27.15% | 15.13% |
| EBITDA | -128.78% | -63.25% | 34.09% | 23.12% | 14.65% |
| EPS Basic | -145.59% | -72.35% | 39.08% | 9.02% | -8.97% |
| Normalized Basic EPS | -119.89% | -55.52% | 39.77% | 10.42% | -7.86% |
| EPS Diluted | -145.59% | -72.35% | 39.08% | 9.02% | -8.97% |
| Normalized Diluted EPS | -119.89% | -55.52% | 39.77% | 10.42% | -7.86% |
| Average Basic Shares Outstanding | 34.94% | 26.25% | 16.83% | 16.36% | 15.87% |
| Average Diluted Shares Outstanding | 34.94% | 26.25% | 16.83% | 16.36% | 15.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |